Submitted by dcc on Mon, 2023-03-06 16:13 Study Title: EAY191-S3, Phase II Study of Paclitaxel (NSC #673089) + Ipatasertib (NSC #781451) in Taxane-Refractory Participants with AKT-Altered Advanced Non-Breast Solid Tumors (A COMBOMATCH Treatment Trial)CIRB: Adult CIRB - Early Phase EmphasisLead Group: ECOGStatus: ActiveReview Status: Available to Open